Tower Research Capital LLC (TRC) - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$9,000
-76.9%
9,344
-71.5%
0.00%
Q1 2022$39,000
-53.6%
32,765
+27.1%
0.00%
-100.0%
Q4 2021$84,000
+55.6%
25,773
+111.7%
0.00%0.0%
Q3 2021$54,000
-60.3%
12,173
-51.4%
0.00%
-75.0%
Q2 2021$136,000
-47.3%
25,046
-27.4%
0.00%0.0%
Q1 2021$258,000
+74.3%
34,500
+153.1%
0.00%
-20.0%
Q4 2020$148,000
-18.2%
13,632
-33.4%
0.01%
+150.0%
Q3 2020$181,000
+103.4%
20,460
+145.7%
0.00%
-50.0%
Q2 2020$89,000
+217.9%
8,326
+209.7%
0.00%
+100.0%
Q3 2019$28,000
+833.3%
2,688
+863.4%
0.00%
Q2 2019$3,000
-94.0%
279
-96.9%
0.00%
-100.0%
Q4 2018$50,000
+316.7%
9,134
+793.7%
0.00%
+300.0%
Q3 2018$12,000
-36.8%
1,022
-44.5%
0.00%0.0%
Q2 2018$19,000
-91.1%
1,840
-91.6%
0.00%
-96.3%
Q4 2017$213,000
+80.5%
21,870
+171.5%
0.03%
+170.0%
Q3 2017$118,000
+11700.0%
8,056
+16340.8%
0.01%
Q1 2017$1,00049
+69.0%
0.00%
Q4 2016$0
-100.0%
29
-98.1%
0.00%
-100.0%
Q3 2016$21,0001,5420.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 4,806,656$58,449,00019.02%
Casdin Capital, LLC 182,141$2,215,0001.83%
Aisling Capital LLC 508,565$6,184,0001.44%
Redmile Group, LLC 948,440$11,533,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,812,778$22,043,0000.91%
EcoR1 Capital, LLC 63,596$773,0000.25%
Eventide Asset Management 150,000$1,824,0000.12%
AWM Investment Company, Inc. 47,550$578,0000.11%
Weiss Multi-Strategy Advisers LLC 49,000$596,0000.03%
Baker Brothers Advisors 204,465$2,486,0000.02%
View complete list of SYROS PHARMACEUTICALS INC shareholders